Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2014

May 13, 2014

284_dirs_2014-05-13_bb6d33da-953f-4596-8d3c-b20330042e78.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-05-09

Reporting Person: FRAZIER KENNETH C (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-09 Common Stock M 9334.0000 $35.0900 Acquired 342385.0630 Direct
2014-05-09 Common Stock M 3542.0000 $31.8400 Acquired 345927.0630 Direct
2014-05-09 Common Stock S 10220.0000 $55.0000 Disposed 335707.0630 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-09 Stock Option (right to buy) $31.8400 M 3542.0000 Disposed 2015-02-24 Common Stock (3542.0000) Direct
2014-05-09 Stock Option (right to buy) $35.0900 M 9334.0000 Disposed 2016-03-02 Common Stock (9334.0000) Direct
2014-05-09 Stock Option (right to buy) $58.2200 A 550206.0000 Acquired 2024-05-08 Common Stock (550206.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401(k) Plan 3470.0603 Indirect

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Holdings include shares acquired in dividend reinvestment transactions.

F3: Includes shares acquired and dividends earned through April 7, 2014, in the Merck U.S. Savings Plan, a 401(k) plan.

F4: The option vests in three equal annual installments beginning May 9, 2015.